J. OH33 reported that the decreased METTL3 expression leads to reduced SRSF11 expression in breast cancer (BRCA), Colon adenocarcinoma (COAD), lung adenocarcinoma (LUAD), and stomach adenocarcinomas (STAD). This evidence concerns the gene SRSF11 and gastric adenocarcinoma.